evans blue has been researched along with Angiogenesis, Pathologic in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (21.43) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 4 (28.57) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, C; Li, M; Niu, J; Teng, Y; Wang, H; Zhang, Y | 1 |
Giraudo, E; Maione, F | 1 |
Chen, X; Dunkel, J; Hou, L; Kalani, MA; Kalani, MY; Prugpichailers, T; Sun, A; Tse, V | 1 |
Lewis, JD; Parseghian, MH; Pink, DB; Schulte, W; Zijlstra, A | 1 |
Knedla, A; Knoth, R; Machein, MR; Neuschl, E; Plate, KH; Wagner, S | 1 |
Olivo, M; Soo, KC; Yee, KK | 1 |
Ackerman, NB; Hechmer, PA; Makohon, S | 1 |
Fukui, M; Ikezaki, K; Matsukado, K; Nomura, T | 1 |
Baluk, P; Lindsey, JR; McDonald, DM; Murphy, TJ; Thurston, G | 1 |
Adamis, AP; D'Amato, RJ; Fernandez, A; Joussen, AM; Liu, S; Ma, JJ; Meyer, TN; Poulaki, V; Redmond, TM; Rohan, RM; Schwesinger, C; Yee, C | 1 |
Bjørnaes, I; Graff, BA; Rofstad, EK | 1 |
Krajewski, S; Wechsler, W | 1 |
Amemiya, K; Kimura, M; Suzuki, J; Yamada, T | 1 |
Brem, S; Goldenberg, M; Zagzag, D | 1 |
14 other study(ies) available for evans blue and Angiogenesis, Pathologic
Article | Year |
---|---|
Tumor vasculature-targeted recombinant mutated human TNF-α enhanced the antitumor activity of doxorubicin by increasing tumor vessel permeability in mouse xenograft models.
Topics: Animals; Antineoplastic Agents; Capillary Permeability; Carcinoma, Hepatocellular; Doxorubicin; Drug Therapy, Combination; Evans Blue; Humans; Liver Neoplasms; Mice; Neovascularization, Pathologic; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays | 2014 |
Tumor angiogenesis: methods to analyze tumor vasculature and vessel normalization in mouse models of cancer.
Topics: Animals; Biological Availability; Blood Vessels; Cell Hypoxia; Cryopreservation; Disease Models, Animal; Doxorubicin; Evans Blue; Fluorescent Antibody Technique; Fluorescent Dyes; Lectins; Mice; Microvessels; Neoplasms; Neovascularization, Pathologic; Pericytes; Permeability | 2015 |
Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Dose-Response Relationship, Drug; Evans Blue; Glioblastoma; Luciferases, Firefly; Luminescence; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Time Factors; Transfection | 2010 |
Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery.
Topics: Animals; Capillary Permeability; Cell Line; Chick Embryo; Chorioallantoic Membrane; Doxorubicin; Drug Delivery Systems; Evans Blue; Humans; Interleukin-2; Microscopy; Neoplasms; Neovascularization, Pathologic; Time-Lapse Imaging; Transplantation, Heterologous; Tumor Microenvironment; Vascular Endothelial Growth Factor A | 2012 |
Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model.
Topics: Angiopoietin-1; Animals; Apoptosis; Blotting, Northern; Blotting, Western; Brain; Brain Neoplasms; Capillaries; Cell Line, Tumor; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Evans Blue; Fluorescent Antibody Technique, Indirect; Genetic Vectors; Glioma; In Situ Hybridization; In Situ Nick-End Labeling; Magnetic Resonance Imaging; Microscopy, Confocal; Microscopy, Fluorescence; Neovascularization, Pathologic; Plasmids; Rats; Rats, Inbred F344; Software | 2004 |
Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Celecoxib; Cyclooxygenase 2; Drug Therapy, Combination; Evans Blue; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Male; Mice; Mice, Inbred BALB C; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neovascularization, Pathologic; Perylene; Photochemotherapy; Pyrazoles; RNA, Messenger; Sulfonamides; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Failure of histamine type mediators to enhance vascular permeability in experimental liver metastases.
Topics: Animals; Bradykinin; Capillary Permeability; Carcinoma 256, Walker; Evans Blue; Histamine; Hyperemia; Liver Neoplasms; Neoplasm Transplantation; Neovascularization, Pathologic; Rats; Serotonin; Time Factors; Transplantation, Homologous | 1980 |
Selective increase in blood-tumor barrier permeability by calcium antagonists in transplanted rat brain tumors.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Calcium Channel Blockers; Cell Line; Cerebral Cortex; Dose-Response Relationship, Drug; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Glioma; Infusions, Intra-Arterial; Male; Neoplasm Transplantation; Neovascularization, Pathologic; Nifedipine; Rats; Rats, Wistar | 1994 |
Angiogenesis in mice with chronic airway inflammation: strain-dependent differences.
Topics: Animals; Capillary Permeability; Cell Count; Chronic Disease; Endothelium, Vascular; Evans Blue; Female; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neovascularization, Pathologic; Pneumonia, Mycoplasma; Silver Staining; Species Specificity; Specific Pathogen-Free Organisms; Substance P; Trachea; Tracheitis; Wheat Germ Agglutinins | 1998 |
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.
Topics: Age Factors; Animals; Bromodeoxyuridine; Capillary Permeability; Cell Adhesion; Cell Division; Choroid; Coloring Agents; Disease Models, Animal; Endothelial Growth Factors; Evans Blue; Leukocytes; Lymphokines; Macular Degeneration; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neovascularization, Pathologic; Pigment Epithelium of Eye; Protein Biosynthesis; Transcription, Genetic; Transgenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.
Topics: Animals; Capillary Permeability; Endothelial Growth Factors; Evans Blue; Female; Humans; Lymphokines; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Serum Albumin; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Development of subrenal capsule tumours following transplantation of rat RN6 multicell spheroids.
Topics: Animals; Biomarkers, Tumor; Evans Blue; Kidney; Necrosis; Neoplasm Invasiveness; Neovascularization, Pathologic; Neurilemmoma; Organoids; Peripheral Nervous System Neoplasms; Rats; Schwann Cells; Subrenal Capsule Assay; Tumor Cells, Cultured | 1991 |
Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice.
Topics: Angiography; Animals; Carmine; Diabetes Mellitus, Experimental; Evans Blue; Freund's Adjuvant; Granuloma; Insulin; Male; Mice; Mice, Inbred ICR; Neovascularization, Pathologic | 1986 |
Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model.
Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Copper; Disease Models, Animal; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Neovascularization, Pathologic; Rabbits; Tomography, X-Ray Computed | 1989 |